Related references
Note: Only part of the references are listed.Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
Tai-Chung Tseng et al.
GUT (2015)
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Antonio Sica et al.
HEPATOLOGY (2014)
Pathological Functions of Interleukin-22 in Chronic Liver Inflammation and Fibrosis With Hepatitis B Virus Infection by Promoting T Helper 17 Cell Recruitment
Juanjuan Zhao et al.
HEPATOLOGY (2014)
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Bi-Sen Ding et al.
NATURE (2014)
The emerging roles of microvesicles in liver diseases
Sara Lemoinne et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cellular Mechanisms of Tissue Fibrosis. 5. Novel insights into liver fibrosis
Ariane Mallat et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
The Immunology of Fibrosis
Georg Wick et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation
John P. Iredale et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
Roeland Zoutendijk et al.
GUT (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
C-C Motif Chemokine Receptor 9 Positive Macrophages Activate Hepatic Stellate Cells and Promote Liver Fibrosis in Mice
Po-sung Chu et al.
HEPATOLOGY (2013)
Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease
Anping Chen et al.
HEPATOLOGY (2013)
Hepatic Macrophages But Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice
Jean-Philippe Pradere et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
Hung-Chih Yang et al.
HEPATOLOGY (2013)
IL-17A Plays a Critical Role in the Pathogenesis of Liver Fibrosis through Hepatic Stellate Cell Activation
Zhongming Tan et al.
JOURNAL OF IMMUNOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
MicroRNAs in liver disease
Gyongyi Szabo et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Therapy for Fibrotic Diseases: Nearing the Starting Line
Scott L. Friedman et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
Hepatic metabolism of retinoids and disease associations
Yohei Shirakami et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway
Wei Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2012)
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
Fanli Meng et al.
GASTROENTEROLOGY (2012)
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
Guanhua Xie et al.
GASTROENTEROLOGY (2012)
Hedgehog Controls Hepatic Stellate Cell Fate by Regulating Metabolism
Yuping Chen et al.
GASTROENTEROLOGY (2012)
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Juliane S. Troeger et al.
GASTROENTEROLOGY (2012)
MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis
Tomohiro Ogawa et al.
GUT (2012)
Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression
Jingjing Jiao et al.
HEPATOLOGY (2012)
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis
Ashley M. Lakner et al.
HEPATOLOGY (2012)
Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice
Felix Heymann et al.
HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Multigenerational epigenetic adaptation of the hepatic wound-healing response
Muejdat Zeybel et al.
NATURE MEDICINE (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Tatiana Kisseleva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques
Frank Tacke et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Hepatic Fibrosis and the Renin-Angiotensin System
Ghulam Abbas et al.
AMERICAN JOURNAL OF THERAPEUTICS (2011)
Anti-fibrogenic strategies and the regression of fibrosis
Tatiana Kisseleva et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with Compensated Cirrhosis
Jose Velosa et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Accelerated Liver Fibrosis in Hepatitis B Virus Transgenic Mice: Involvement of Natural Killer T Cells
Zixue Jin et al.
HEPATOLOGY (2011)
Human T Cell Microparticles Circulate in Blood of Hepatitis Patients and Induce Fibrolytic Activation of Hepatic Stellate Cells
Miroslaw Kornek et al.
HEPATOLOGY (2011)
Micro-RNA Profiling Reveals a Role for miR-29 in Human and Murine Liver Fibrosis
Christoph Roderburg et al.
HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany et al.
HEPATOLOGY (2011)
Epigenetic cell fate regulation of hepatic stellate cells
Hidekazu Tsukamoto et al.
HEPATOLOGY RESEARCH (2011)
IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF-β-Independent Smad Signaling
Yan Liu et al.
JOURNAL OF IMMUNOLOGY (2011)
Hepatic Stellate Cells Function as Regulatory Bystanders
Shintaro Ichikawa et al.
JOURNAL OF IMMUNOLOGY (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response
Conrado M. Fernandez-Rodriguez et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Treatment of Patients With HCV-Related Cirrhosis With Peginterferon and Ribavirin: Swinging the Pendulum Toward Treatment
Mazen Noureddin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Production of Erythropoietin by Liver Cells in Vivo and in Vitro
K.-U. ECKARDT et al.
Annals of the New York Academy of Sciences (2010)
PRM-151 (RECOMBINANT HUMAN SERUM AMYLOID P/PENTRAXIN 2) FOR THE TREATMENT OF FIBROSIS
Jeremy S. Duffield et al.
DRUG NEWS & PERSPECTIVES (2010)
Genetic Labeling Does Not Detect Epithelial-to-Mesenchymal Transition of Cholangiocytes in Liver Fibrosis in Mice
David Scholten et al.
GASTROENTEROLOGY (2010)
Prognostic Value of Ishak Fibrosis Stage: Findings from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
James E. Everhart et al.
HEPATOLOGY (2010)
Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus-Induced Cirrhosis. A 12-Year Prospective Follow-up Study
Savino Bruno et al.
HEPATOLOGY (2010)
CX3CL1-CX3CR1 Interaction Prevents Carbon Tetrachloride-Induced Liver Inflammation and Fibrosis in Mice
Tomonori Aoyama et al.
HEPATOLOGY (2010)
The Fractalkine Receptor CX3CR1 Protects Against Liver Fibrosis by Controlling Differentiation and Survival of Infiltrating Hepatic Monocytes
Karlin Raja Karlmark et al.
HEPATOLOGY (2010)
Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Kojiro Taura et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Hepatitis C Virus Seromarkers and Subsequent Risk of Hepatocellular Carcinoma: Long-Term Predictors From a Community-Based Cohort Study
Mei-Hsuan Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
Yan Wang et al.
JOURNAL OF HEPATOLOGY (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
Jonel Trebicka et al.
JOURNAL OF HEPATOLOGY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
A Patient with Chronic Hepatitis B and Regression of Fibrosis during Treatment
Charissa Y. Chang et al.
SEMINARS IN LIVER DISEASE (2010)
Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease
Olivier Rosmorduc et al.
SEMINARS IN LIVER DISEASE (2010)
Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study
Savino Bruno et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Liver Cell-Derived Microparticles Activate Hedgehog Signaling and Alter Gene Expression in Hepatic Endothelial Cells
Rafal P. Witek et al.
GASTROENTEROLOGY (2009)
The Interleukin-17 Pathway Is Involved in Human Alcoholic Liver Disease
Arnaud Lemmers et al.
HEPATOLOGY (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
A Seven-Gene Signature (Cirrhosis Risk Score) Predicts Liver Fibrosis Progression in Patients with Initially Mild Chronic Hepatitis C
Moira Marcolongo et al.
HEPATOLOGY (2009)
The Etiology of Liver Damage Imparts Cytokines Transforming Growth Factor β1 or Interleukin-13 as Driving Forces in Fibrogenesis
Hong-Lei Weng et al.
HEPATOLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages
Kamran Atabai et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Therapeutic targeting of the PDGF and TGF-β-signaling pathways in hepatic stellate cells by PTK787/ZK22258
Yuqing Liu et al.
LABORATORY INVESTIGATION (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Brief communication: The relationship of regression of cirrhosis to outcome in chronic hepatitis C
Vincent Mallet et al.
ANNALS OF INTERNAL MEDICINE (2008)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
Kojiro Taura et al.
GASTROENTEROLOGY (2008)
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan
Chi-Ling Chen et al.
GASTROENTEROLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells
Samuel Martin-Vilchez et al.
HEPATOLOGY (2008)
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
Hla-Hla Thein et al.
HEPATOLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
Yasushi Sato et al.
NATURE BIOTECHNOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Hepatitis c virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen-year prospective cohort study
Savino Bruno et al.
HEPATOLOGY (2007)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients
Chee-Kin Hui et al.
HEPATOLOGY (2007)
Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition
Michael Zeisberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis
Stuart Roberts et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
Chee-Kin Hui et al.
HEPATOLOGY (2007)
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C
Honjin Huang et al.
HEPATOLOGY (2007)
Liver fibrosis and chronic viral hepatitis
Gabriela Gutierrez-Reyes et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Molecular mechanisms of hepatic fibrogenesis
Christopher J. Parsons et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells
Erica Novo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Gene expression profiles during hepatic stellate cell activation in culture and in vivo
Samuele De Minicis et al.
GASTROENTEROLOGY (2007)
Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis
Jonathan A. Fallowfield et al.
JOURNAL OF IMMUNOLOGY (2007)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
IFN-γ abrogates profibrogenic TGF-β signaling in liver by targeting expression of inhibitory and receptor Smads
Honglei Weng et al.
JOURNAL OF HEPATOLOGY (2007)
Emerging insights into transforming growth factor β Smad signal in hepatic fibrogenesis
Y. Inagaki et al.
GUT (2007)
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
Savino Bruno et al.
HEPATOLOGY (2007)
Ito cells are liver-resident antigen-presenting cells for activating T cell responses
Florian Winau et al.
IMMUNITY (2007)
Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats
Guangming Li et al.
JOURNAL OF GENE MEDICINE (2006)
Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
C. -H. Hung et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis
SM Kamal et al.
HEPATOLOGY (2006)
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC
DF Calvisi et al.
GASTROENTEROLOGY (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Hepatitis C virus load and survival among injection drug users in the United States
M Hisada et al.
HEPATOLOGY (2005)
Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B
Nusret Akpolat et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-β1 and α-smooth muscle actin in rats with hepatic fibrosis
Xin-Ming Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Adipogenic transcriptional regulation of hepatic stellate cells
HY She et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
JS Duffield et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Angiogenesis and hepatocellular carcinoma
D Semela et al.
JOURNAL OF HEPATOLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Transforming growth factor (TGF)-β1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-β1-mediated fibrosis
A Kitani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production
A Di Sario et al.
JOURNAL OF HEPATOLOGY (2002)
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
T Poynard et al.
GASTROENTEROLOGY (2002)
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1
CG Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Hepatic blood flow regulation by stellate cells in normal and injured liver
DC Rockey
SEMINARS IN LIVER DISEASE (2001)
Medical progress: Hepatitis C virus infection.
GM Lauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Hepatitis B genotypes and the response to interferon therapy
JH Kao et al.
JOURNAL OF HEPATOLOGY (2000)
Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study
M Wiese et al.
HEPATOLOGY (2000)
Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2000)
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
JH Kao et al.
GASTROENTEROLOGY (2000)
Share Paper
